T2D-Bench: Evidence-Gated Evaluation of LLM Outputs for Type 2 Diabetes Using a Multi-Layer Clinical-Lifestyle Knowledge Graph

Large language models (LLMs) offer promising clinical decision support but remain vulnerable to hallucinated facts, unsupported recommendations, and citation errors. We present DIASENTINEL, a fully on-premise multi-agent system for one-year type 2 diabetes mellitus (T2DM) risk screening and guideline-grounded report generation from electronic health records (EHRs). The system integrates calibrated risk prediction, deterministic clinical signal extraction, Reciprocal Rank Fusion over American Diabetes Association (ADA) guidelines, and a hybrid verification layer combining rule-based checks with LLM entailment. The demonstration provides a real-time batch-screening dashboard and an interactive patient report interface with cited recommendations, verification results, and raw EHR comparison. DIASENTINEL demonstrates a practical framework for reliable, auditable, and privacy-preserving LLM-based clinical decision support.

Several studies have evaluated the ability of Large Language Models (LLMs) for meal planning, yielding positive outcomes. These models can process natural language inputs and leverage learned knowledge from their pretraining to generate meal plans. In this work, we investigate the ability of LLMs to analyze the suitability of given recipes for diabetes. The primary challenge for LLMs is to retrieve relevant dietary guidelines for diabetes, decompose recipes into ingredients and cooking methods, and apply these guidelines to determine the recipe's suitability. To study these challenges, we employ three kinds of prompts namely, (i) Direct Query Prompt (ii) Context-Guided Prompt, and (iii) Exemplary Context Prompt that incorporate different levels of diabetes dietary guidelines from medical sources. We introduce a benchmark dataset curated for this investigation consisting of 7607 recipes that include 3807 recipes suitable for diabetes and 3800 recipes not suitable for diabetes. Our results demonstrate that most LLMs are cautious in predicting recipes as suitable to prevent detrimental outcomes. Further, the models that can reason using the dietary guidelines performed better in predicting the suitability of recipes for diabetes. Overall, Mistral-7B and Llama 70B showed superior performance to their counterparts.

Type 2 Diabetes (T2D) poses an increasing global health threat, demanding effective glycemic assessment to support personalized and improved diabetes care. Wearable sensors such as continuous glucose monitors (CGM) and fitness trackers offer many valuable insights for glycemic assessment. However, effectively analyzing these data requires integration with essential individual-level context. Existing methods are often based on traditional machine learning (ML) and rely primarily on historical blood glucose measurements and overlook personalized information, which limits their performance across diverse diabetes populations. Recent advances in large language models (LLMs) have demonstrated their ability to integrate diverse data modalities while modeling sequential dependencies, motivating the exploration of their potential for personalized glycemic assessment. In this paper, we propose GlyLLM, an LLM-powered framework for modeling CGM-based glycemic dynamics through the integration of wearable sensor data and structured metadata. GlyLLM can leverage the extensive prior knowledge of pre-trained LLMs and achieve sensor-text semantic abstraction at decision time. Experiments on two related tasks on the AI-READI dataset demonstrate that our model outperforms traditional ML methods by an average of 13.66% in Root Mean Squared Error (RMSE) for glucose forecasting and 13.08% in Area Under the Receiver Operating Characteristic (AUROC) for diabetes categorization. Additionally, our ablation study shows that diabetes surveys and biometric tests are more critical than other health information for glycemic assessment. Our work presents a promising step toward harnessing the power of LLMs to advance personalized glycemic assessment in T2D care.